Stablepoint Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
DC
GI
MAA
CGH
CNB
Stablepoint Partners's MDT Position: Q2 2026 in Review
Stablepoint Partners increased its Medtronic (MDT) stake by 1.4% in Q2 2026, buying an estimated $84.9K and bringing the position to 74,189 shares worth $5.8M. The position accounts for 0.8% of the portfolio, ranked #43.
Stablepoint Partners first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.8M in Q4 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Stablepoint Partners held 74,189 shares of Medtronic worth $5.8M as of Q2 2026.
- Stablepoint Partners bought 1,052 Medtronic shares in Q2 2026, an estimated $84.9K.
- Medtronic made up 0.8% of Stablepoint Partners's portfolio in Q2 2026, its #43 holding.
- Stablepoint Partners first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
- Stablepoint Partners's Medtronic position peaked at $6.8M in Q4 2025.
- 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.